Showing results (11-20 of 129) with videos related to
Sort By:
Pageof 13
Leukemia & Lymphoma|January 8, 2015
Novel therapeutic options for relapsed hairy cell leukemiaPreetesh Jain, Aaron Polliack, Farhad RavandiCurrent Treatment Options in Oncology|April 11, 2013
Chronic myeloid leukemia: overview of new agents and comparative analysisPreetesh Jain, Hagop Kantarjian, Jorge CortesJournal of Hematology & Oncology|September 25, 2020
Advances in the assessment of minimal residual disease in mantle cell lymphomaDayoung Jung, Preetesh Jain, Yixin Yao, et al.Therapeutic Advances in Hematology|June 2, 2022
Zanubrutinib in lymphoproliferative disorders: a comprehensive reviewJavier Muñoz, Yucai Wang, Preetesh Jain, et al.Drugs of Today (Barcelona, Spain : 1998)|June 7, 2022
Brexucabtagene autoleucel: a breakthrough in the treatment of mantle cell lymphomaAnagha Deshpande, Yucai Wang, Javier Munoz, et al.Current Oncology Reports|May 21, 2022
BTK Inhibitors and CAR T-Cell Therapy in Treating Mantle Cell Lymphoma-Finding a Dancing PartnerJavier L Munoz, Yucai Wang, Preetesh Jain, et al.Indian Journal of Cancer|November 20, 2008
Neoadjuvant chemotherapy or chemoradiotherapy in head and neck cancerPreetesh Jain, Prabhash Kumar, Vasanth Raghuvir Pai, et al.American Journal of Hematology|May 23, 2013
Recent advances in de novo CD5+ diffuse large B cell lymphomaPreetesh Jain, Luis E Fayad, Andreas Rosenwald, et al.Clinical Nuclear Medicine|December 23, 2016
FDG PET/CT in Malignant Eccrine SpiradenomaGabriela Sanchez Petitto, Nawid M Sarwari, Preetesh Jain, et al.Current Treatment Options in Oncology|October 13, 2022
Is There Still a Role for Transplant for Patients with Mantle Cell Lymphoma (MCL) in the Era of CAR-T Cell Therapy?Amer Beitinjaneh, Adrienne Kaufman, Yucai Wang, et al.Pageof 13